AstraZeneca PLC (AZN) vs PepsiCo, Inc. (PEP)
AZN leads on 10 of 15 compared metrics, though PEP is the cheaper stock.
A side-by-side comparison of AstraZeneca PLC and PepsiCo, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs PEP
growth of $100 · last 30yAZN +732.9%PEP +333.9%AZN compounded faster
AZN PEP
AZN vs PEP: by the numbers
- •AZN is the larger company ($277.22B vs $197.21B market cap).
- •PEP trades at the lower earnings multiple (22.65 vs 26.92 P/E).
- •AZN converts more revenue to profit (17.19% vs 9.16% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 6.00% CAGR).
- •PEP pays the higher dividend yield (3.98% vs 1.79%).
Which is better, AZN or PEP?
Metric tally: AZN 10 · PEP 5It depends on what you're optimizing for:
ValuePEP(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomePEP(higher dividend yield)
Metrics side by side
Valuation
| Metric | AZN | PEP |
|---|---|---|
| P/E ratio | 26.92 | 22.65● |
| Forward P/E | 15.33● | 15.87 |
| P/S ratio | 4.62 | 2.07● |
| P/B ratio | 5.90● | 9.25 |
| PEG ratio | 0.14● | 9.44 |
| EV / EBITDA | 14.92 | 14.74 |
| FCF yield | 2.89% | 4.47%● |
Profitability
| Metric | AZN | PEP |
|---|---|---|
| Gross margin | 81.68%● | 54.06% |
| Operating margin | 23.69%● | 14.79% |
| Net margin | 17.19%● | 9.16% |
| ROE | 21.95% | 40.89%● |
| ROIC | 13.03% | 13.29% |
Dividends
| Metric | AZN | PEP |
|---|---|---|
| Dividend yield | 1.79% | 3.98%● |
| Payout ratio | 48.48% | 95.32% |
Growth (annualized)
| Metric | AZN | PEP |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 6.00% |
| EPS CAGR (5Y) | 22.02%● | 2.40% |
| FCF CAGR (5Y) | 15.68%● | 6.62% |
| Total return CAGR (5Y) | 11.03%● | 2.72% |
Frequently asked
- Which is better, AZN or PEP?
- It depends on your goal. value: PEP (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: PEP (higher dividend yield). Across all compared metrics, AZN leads 10 to 5.
- Is AZN or PEP cheaper?
- On trailing earnings, PEP is cheaper: AZN trades at a 26.92 P/E and PEP at 22.65.
- Which has grown faster, AZN or PEP?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus PEP at 6.00%.
- Does AZN or PEP pay a bigger dividend?
- AZN yields 1.79% and PEP yields 3.98% based on trailing dividends and the latest price.
- Is AZN or PEP more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus PEP at 9.16%.
- Which has been the better investment, AZN or PEP?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus PEP at 6.61%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioPepsiCo P/E ratioAstraZeneca dividend yieldPepsiCo dividend yieldAstraZeneca ROEPepsiCo ROEAstraZeneca operating marginPepsiCo operating marginAstraZeneca revenue growthPepsiCo revenue growthAstraZeneca free cash flowPepsiCo free cash flow
AstraZeneca & PepsiCo appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.